SCHEMBL14083065

SCHEMBL14083065

CCN(CC)c1ccc(NC(=O)c2ccc(-c3ncccc3C(F)(F)F)c(OC)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 10/20 0.60
▸ MAPT P10636 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ LMNA P02545 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ NPSR1 Q6W5P4 2/20 0.47
▸ GFER P55789 1/20 0.47
▸ GHSR Q92847 1/20 0.47
▸ HTT P42858 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ AURKB Q96GD4 1/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ NOX1 Q9Y5S8 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14084085 0.89 TRPV1 (0.62) TRPV1MAPTALDH1A1LMNAMAPK1
SCHEMBL14083298 0.88 GHSR (0.54) TRPV1MAPTALDH1A1LMNAMAPK1
SCHEMBL14083242 0.88 TRPV1 (0.61) TRPV1MAPTALDH1A1LMNAMAPK1
SCHEMBL14083070 0.88 TRPV1 (0.78) TRPV1
SCHEMBL14083064 0.87 TRPV1 (0.65) TRPV1MAPTALDH1A1LMNAAURKB
SCHEMBL14083068 0.87 TRPV1 (0.64) TRPV1MAPTLMNAGAAAURKB
SCHEMBL14083072 0.86 TRPV1 (0.71) TRPV1MAPT
SCHEMBL14083771 0.86 ALDH1A1 (0.54) TRPV1MAPTALDH1A1LMNAMAPK1
SCHEMBL14083086 0.85 TRPV1 (0.63) TRPV1MAPTLMNAHTTGAA
SCHEMBL14083075 0.85 TRPV1 (0.58) TRPV1MAPTLMNAHTTAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 TRPV1 1/4885MAPT 2822/4885ALDH1A1 1577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback